Experimental hyperlipidemia dramatically reduces access of insulin to canine skeletal muscle

Obesity

Volumn 17, Issue 8, 2009, Pages 1486-1492

  Chiu, Jenny D ^a   Kolka, Cathryn M ^a   Richey, Joyce M ^a   Harrison, Lisa N ^a   Zuniga, Edward ^a   Kirkman, Erlinda L ^a   Bergman, Richard N ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GLUCOSE; INSULIN; LIPID;

ANIMAL; ARTICLE; BIOLOGICAL MODEL; CHEMISTRY; DOG; HYPERLIPIDEMIA; INSULIN RESISTANCE; LIPID METABOLISM; MALE; METABOLISM; OBESITY; SKELETAL MUSCLE; SWINE; TIME;

ANIMALS; DOGS; FATTY ACIDS, NONESTERIFIED; GLUCOSE; HYPERLIPIDEMIAS; INSULIN; INSULIN RESISTANCE; LIPID METABOLISM; LIPIDS; MALE; MODELS, BIOLOGICAL; MUSCLE, SKELETAL; OBESITY; SWINE; TIME FACTORS;

ANIMALIA; CANIS FAMILIARIS;

EID: 67749114141     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2009.165     Document Type: Article

References (34)

1. Bergman RN. Orchestration of glucose homeostasis: from a small acorn to the California oak. Diabetes 2007;56:1489-1501.
2. Kahn R. Metabolic syndrome: is it a syndrome? Does it matter? Circulation 2007;115:1806-10; discussion 1811.
3. Virkamäki A, Korsheninnikova E, Seppälä-Lindroos A et al. Intramyocellular lipid is associated with resistance to in vivo insulin actions on glucose uptake, antilipolysis, and early insulin signaling pathways in human skeletal muscle. Diabetes 2001;50:2337-2343.
4. Tanner JW, Leingang KA, Mueckler MM, Glenn KC. Cellular mechanism of the insulin-like effect of growth hormone in adipocytes. Rapid translocation of the HepG2-type and adipocyte/muscle glucose transporters. Biochem J 1992;282 (Pt 1):99-106.
5. Björnholm M, Zierath JR. Insulin signal transduction in human skeletal muscle: identifying the defects in Type II diabetes. Biochem Soc Trans 2005;33:354-357.
6. Krebs M, Roden M. Molecular mechanisms of lipid-induced insulin resistance in muscle, liver and vasculature. Diabetes Obes Metab 2005;7:621-632.
7. Le Marchand-Brustel Y, Gual P, Grémeaux T et al. Fatty acid-induced insulin resistance: role of insulin receptor substrate 1 serine phosphorylation in the retroregulation of insulin signalling. Biochem Soc Trans 2003;31:1152-1156.
8. Morino K, Petersen KF, Shulman GI. Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction. Diabetes 2006;55 Suppl 2:S9-S15.
9. Baron AD, Clark MG. Role of blood flow in the regulation of muscle glucose uptake. Annu Rev Nutr 1997;17:487-499.
10. Ellmerer M, Hamilton-Wessler M, Kim SP et al. Reduced access to insulin-sensitive tissues in dogs with obesity secondary to increased fat intake. Diabetes 2006;55:1769-1775.
11. Clark MG, Wallis MG, Barrett EJ et al. Blood flow and muscle metabolism: a focus on insulin action. Am J Physiol Endocrinol Metab 2003;284:E241-E258.
12. Gudbjornsdottir S, Sjostrand M, Strindberg L, Lonnroth P. Decreased muscle capillary permeability surface area in type 2 diabetic subjects. J Clin Endocrinol Metab 2005;90:1078-1082.
13. Belfort R, Mandarino L, Kashyap S et al. Dose-response effect of elevated plasma free fatty acid on insulin signaling. Diabetes 2005;54:1640-1648.
14. Roden M, Krssak M, Stingl H et al. Rapid impairment of skeletal muscle glucose transport/phosphorylation by free fatty acids in humans. Diabetes 1999;48:358-364.
15. Jucker BM, Rennings AJ, Cline GW, Shulman GI. 13C and 31P NMR studies on the effects of increased plasma free fatty acids on intramuscular glucose metabolism in the awake rat. J Biol Chem 1997;272:10464-10473.
16. Yu C, Chen Y, Cline GW et al. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem 2002;277:50230-50236.
17. Kim YI, Lee FN, Choi WS, Lee S, Youn JH. Insulin regulation of skeletal muscle PDK4 mRNA expression is impaired in acute insulin-resistant states. Diabetes 2006;55:2311-2317.
18. Brechtel K, Dahl DB, Machann J et al. Fast elevation of the intramyocellular lipid content in the presence of circulating free fatty acids and hyperinsulinemia: a dynamic 1H-MRS study. Magn Reson Med 2001;45:179-183.
19. Vincent MA, Clerk LH, Lindner JR et al. Microvascular recruitment is an early insulin effect that regulates skeletal muscle glucose uptake in vivo. Diabetes 2004;53:1418-1423.
20. Miles PD, Levisetti M, Reichart D et al. Kinetics of insulin action in vivo. Identification of rate-limiting steps. Diabetes 1995;44:947-953.
21. Chiu JD, Richey JM, Harrison LN et al. Direct administration of insulin into skeletal muscle reveals that the transport of insulin across the capillary endothelium limits the time course of insulin to activate glucose disposal. Diabetes 2008;57:828-835.
22. Yang YJ, Hope I, Ader M, Poulin RA, Bergman RN. Dose-response relationship between lymph insulin and glucose uptake reveals enhanced insulin sensitivity of peripheral tissues. Diabetes 1992;41: 241-253.
23. Sjostrand M, Holmang A, Strindberg L, Lonnroth P. Estimations of muscle interstitial insulin, glucose, and lactate in type 2 diabetic subjects. Am J Physiol Endocrinol Metab 2000;279:E1097-E1103.
24. Nystrom FH, Quon MJ. Insulin signalling: metabolic pathways and mechanisms for specificity. Cell Signal 1999;11:563-574.
25. Roden M, Stingl H, Chandramouli V et al. Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans. Diabetes 2000;49:701-707.
26. Bachmann OP, Dahl DB, Brechtel K et al. Effects of intravenous and dietary lipid challenge on intramyocellular lipid content and the relation with insulin sensitivity in humans. Diabetes 2001;50:2579-2584.
27. Petersen KF, Befroy D, Dufour S et al. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 2003;300:1140-1142.
28. Clerk LH, Rattigan S, Clark MG. Lipid infusion impairs physiologic insulin-mediated capillary recruitment and muscle glucose uptake in vivo. Diabetes 2002;51:1138-1145.
29. Storz P, Döppler H, Wernig A, Pfizenmaier K, Müller G. Cross-talk mechanisms in the development of insulin resistance of skeletal muscle cells palmitate rather than tumour necrosis factor inhibits insulin-dependent protein kinase B (PKB)/Akt stimulation and glucose uptake. Eur J Biochem 1999;266:17-25.
30. Schmitz-Peiffer C, Craig DL, Biden TJ. Ceramide generation is sufficient to account for the inhibition of the insulin-stimulated PKB pathway in C2C12 skeletal muscle cells pretreated with palmitate. J Biol Chem 1999;274:24202-24210.
31. Wang H, Liu Z, Li G, Barrett EJ. The vascular endothelial cell mediates insulin transport into skeletal muscle. Am J Physiol Endocrinol Metab 2006;291:E323-E332.
32. St-Pierre P, Bouffard L, Papirakis ME, Maheux P. Increased extravasation of macromolecules in skeletal muscles of the Zucker rat model. Obesity (Silver Spring) 2006;14:787-793.
33. Dell'Omo G, Penno G, Pucci L et al. Abnormal capillary permeability and endothelial dysfunction in hypertension with comorbid Metabolic Syndrome. Atherosclerosis 2004;172:383-389.
34. Chakir M, Plante GE, Maheux P. Reduction of capillary permeability in the fructose-induced hypertensive rat. Am J Hypertens 1998;11:563-569.